Cytokeratin 19 Mouse mAb IHC Kit
Product Specifications
Background
CK19 is a cytokeratin with a molecular weight of 40 kDa. It is mainly expressed in monolayer epithelium and ductal epithelium, and can be detected in the basal layer of squamous epithelium and epidermis. It is a good marker of epithelial differentiation. It is mainly used for the diagnosis of adenocarcinoma. Hepatocytes do not express CK19, but bile duct epithelium does, so it can be used to distinguish hepatocellular carcinoma from intrahepatic cholangiocarcinoma and metastatic adenocarcinoma. CK19 is partially or weakly expressed in normal thyroid tissue, follicular adenoma, nodular goiter and papillary hyperplasia, but it can be diffusely and strongly expressed in thyroid papillary carcinoma.
Synonyms
40 kDa keRatin intermediate filament, CK 19, CK-19, CK19, Cytokeratin 19, CytokeRatin-19, K19, K1C19_HUMAN, K1CS, KeRatin 19, KeRatin type I 40 kD, KeRatin type I 40kD, KeRatin type I cytoskeletal 19, KeRatin, type I cytoskeletal 19, KeRatin, type I, 40 kd, KeRatin-19, KRT19, MGC15366
Gene Name
KRT19
Gene ID
3880
Swiss Prot
P08727
Reactivity
Human
Immunogen
A synthetic peptide corresponding to the amino acid region 300 - 400 of the human Cytokeratin 19 protein.
Applications
Immunohistochemistry (IHC)
Dilution
It has been optimized for direct use, requiring no further dilution.
Specificity
The antibody can specifically recognize human CK19 protein, and shows no cross reaction with CK1, 5, 6, 7, 8, 10, 13, 14, 15, 17, 18, 20.
Formulation
The ready - to - use antibody is provided in liquid form in phosphate buffer saline containing stabilizing protein and 0. 05% Proclin 300.
Subcellular Location
Cytoplasmic, Membranous
Protein Name
Cytokeratin 19
Available Sizes
More Discoveries
Explore Other Products
Browse additional items from our catalog